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ABSTRACT
INTRODUCTION: During the period 2000-2001, clinical pathways were developed and implemented as a 
temporary solution for financing the hospitals in Bulgaria. The aim of this article is to study and trace the 
application of clinical pathways as a tool for hospital funding in Bulgaria.
MATERIALS AND METHODS: In order to examine the implementation and the progress of CPs in Bul-
garian hospitals we have studied Bulgarian and foreign publications. In addition to this, we have also in-
cluded official reports published by the Ministry of Health, Ministry of Finance, National Health Insurance 
Fund (NHIF), the National Center of Public Health and Analyses (NCPHA) and others.
RESULTS AND DISCUSSION: CPs were negotiated and included for the first time in the National Frame-
work Contract in 2001. Gradually, the number of CPs increased and reached more than 300 in 2015. The in-
troduction of CPs as a tool for financing hospital care is related to the need of fixing the prices of the respec-
tive CPs. Initially, the NHIF and the Bulgarian Medical Association developed a common methodology for 
fixing the prices of CPs. From 2011, an amendment to the Health Insurance Act stipulates that the proce-
dures for valuation and payment of activities by NHIF are defined by specific methodologies. We have found 
that not all hospitals submit information to the specialized software for hospitals which is the only tool for 
analyzing the costs structure in the health care establishments at present.
CONCLUSION: The clinical pathways are not accepted as a sufficient effective mechanism for hospital 
funding in Bulgaria. Moreover, the lack of accurate and comparable information makes the analyses incom-
plete and vulnerable.
Keywords: clinical pathways, hospitals,  financing, cost, pricing, Bulgaria
INTRODUCTION
Clinical pathways (CPs) are introduced in 
health care in the early 1980s in the United States. 
For the first time, the CPs were used systematical-
ly between 1985 and 1987 in the New England Med-
ical Center in Boston (USA) in response to the in-
troduction of Diagnosis-Related Groups (DRG) in 
1983. In the early 1990s CPs were introduced in the 
United Kingdom. Currently, CPs are used world-
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wide as a complex intervention (1). The widespread 
use of CPs presumes the presence of different defi-
nitions of their nature. The European Pathway As-
sociation define a CP as: “A complex intervention 
for the mutual decision-making and organization of 
predictable care for a well-defined group of patients 
during a well-defined period” (1).  According to oth-
er authors “The clinical pathway coordinates the ex-
pected care and treatment, provided by a multidisci-
plinary team of specialists, towards a patient in cer-
tain condition or in a group of similar conditions, in 
generally agreed time frame in order to achieve cer-
tain results. Any deviation from the plan is defined 
as “variation”. Its study helps for reconsidering the 
current practice“ (2). Bulgarian experts added and 
specified that “a clinical pathway is a structured mul-
tidisciplinary plan which aims to achieve clearly de-
fined clinical purposes and describes in details the 
basic steps in providing care for a patient with a spe-
cific medical problem” (3). Other experts perceive the 
CP as an “organizational, diagnostic and therapeu-
tic algorithm which resolves the growing conflict be-
tween the clinical freedom and the health care man-
agement through the balance between the medical 
and economic feasibility” (4).
The introduction of the social health insurance 
model in Bulgaria is associated with many discus-
sions and intentions to introduce DRG as a method 
for financing hospitals (5). Despite the thorough re-
search on international experience and the experi-
mental application of case mix approach and DRG 
in Bulgaria, the CPs were developed and implement-
ed in 2000-2001. Initially they were perceived as a 
temporary solution for financing hospitals since it is 
considered that they are a preferred mechanism for 
quality control and are not appropriate as a funding 
method (6).
The aim of this article is to study and trace the 
application of clinical pathways as a tool for hospital 
funding in Bulgaria.
MATERIALS AND METHODS
To review the implementation and the progress 
of CPs in Bulgarian hospitals we have studied Bul-
garian and foreign publications. In addition to this, 
we have also included official reports published by 
the Ministry of Health, the Ministry of Finance, the 
National Health Insurance Fund (NHIF), the Na-
tional Center of Public Health and Analyses (NC-
PHA) and others.
RESULTS AND DISCUSSION
The transformation of the tax-based health care 
system into a social health insurance system imposed 
a different approach in the generation and distribu-
tion of funds for the different levels of the health care 
system. Furthermore, the key feature of the new sys-
tem is the negotiation between the professional as-
sociations of physicians and dentists and the NHIF 
as the only responsible organization for the payment 
of contracted services. The relationships between the 
NHIF and health care providers are based on the Na-
tional Framework Contract (NFC). CPs are negoti-
ated and included in NFC for the first time in 2001 
as NHIF paid for only 21 CPs. Gradually, the num-
ber of CPs increased to 30 in 2002, 81 in the years 
2003-2004, and to 120 in 2005 (7). For the treatment 
of patients with diagnoses that are not included in 
the CPs, hospitals receive funding from the Minis-
try of Health which is based on a budget. Since 2006, 
inpatient hospital services have been financed main-
ly by the NHIF. As of 2015, the number of CPs has 
increased to more than 300 (currently 311) (8). One 
of the main principles of the changes in the scope 
of CPs is grouping together of diagnoses and proce-
dures which require similar resources. The expecta-
tions of this distribution are that patients with the 
same degree of complexity of a disease and similar 
levels of required resources will fall into the same 
CP. A crucial aspect in the development of the CPs is 
the multidisciplinary approach with consensual so-
lutions in order to achieve common agreement be-
tween groups of experts.
The introduction of CPs as a tool for financing 
hospital care is related to the need of fixing the pric-
es of the respective CPs. For this purpose, the Bul-
garian Medical Association and the NHIF developed 
a common methodology for fixing the prices of CPs. 
A calculation of weighted average cost approach was 
applied - the total amount of the individual costs of 
the patients gathered in the respective CP, is divided 
by the total number of patients for this CP. The aver-
age cost of CPs is calculated at the level of municipal, 
regional, and university hospitals, while the actual 
calculation for different types of hospitals applies:
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 ❖ trimming of costs - a process in which extreme-
ly high and unrealistically low reported costs 
are not included in the calculation, thus it is not 
allowing interference over the normal distribu-
tion of costs incurred in hospitals;
 ❖ the estimated average costs by CPs for the dif-
ferent types of hospitals are weighed by the 
number of reported cases, thus defining a price 
at national level;
 ❖ defined prices for CPs at national level are in-
creased by percentage, which reflects the dy-
namics of the cost of reported cases by adding 
the expected rate of inflation;
The application of this methodology reveals a 
problem, which relates to the practice of negotiat-
ing the CPs prices between the professional orga-
nizations of physicians and the NHIF. This in turn 
led to a lack of connection between the reported CP 
costs by hospitals (according to the cited methodolo-
gy) and the price which NHIF pays.
According to the experts, financing the CPs in 
accordance with the above-mentioned method sets a 
number of limitations. Thus, financing requires im-
plementation of additional tools to restrict the hospi-
tal costs - namely hospital budgets (global budgets) 
(9). In the light of these two tools (CPs and hospital 
budgets), reimbursement rates and methods of valu-
ation and payment of medical services have been de-
signed - “which aim at a fairer redistribution of public 
funds” (9). As of 2011, an amendment to the Health 
Insurance Act stipulates that the procedures for valu-
ation and payment of activities by NHIF are defined 
by specific methodologies. These methodologies are 
developed by NHIF and are sent to the Minister of 
Finance and the Minister of Health for opinion. The 
Minister of Health submits the approved methodol-
ogies for adoption to the Council of Ministers. This 
way, the approved methodologies become regula-
tions, therefore, mandatory for all participants in the 
health insurance system (10). The methodologies are 
developed by all types of activities and are comprised 
of two components – methodology for payment and 
methodology for valuation of the activities. The pay-
ment methodology includes specific rules according 
to which the health care establishments should carry 
out and report the medical activities, while the valu-
ation methodology comprises rules (incl. mathemat-
ical ones) which determine the prices which NHIF 
pays to the health care establishments (10).
One of the main problems regarding the valu-
ation of medical services is the reliability of the re-
ported information. This issue is related to the lack 
of identical methodology for reporting the costs and 
costs calculation at the level of the patient (11,12). 
Thus, a gap in the reporting of the various types of 
costs in the various hospitals is observed. This prob-
ably is one of the reasons which explain the serious 
variations in the presented data upon the analysis of 
the experts. This fact in turn emphasizes the need of 
quality accounting information and usefulness of its 
subsequent analysis and interpretation. Another rea-
son for the incorrect calculation of the CP cost is the 
amount of unaccounted costs in hospital accounting. 
Such costs, for example, are the costs for food that 
are fully paid by the patients, the costs for medicines, 
consumables and others that the patients buy them-
selves, in some cases, expenses for sheets and others. 
This in turn leads to incomplete and insufficient-
ly precise calculation of the treatment of a sick per-
son who has used the pathway. Thus, it is impossi-
ble to calculate the total cost of treatment and, hence, 
to define the price which would be formed based on 
the cost of the service. According to the health care 
managers in Bulgarian hospitals such costs have to 
be made due to the lack of funds and the insufficient 
financing of the health care system in general. The 
unaccounted and unregistered payments are a seri-
ous problem in Bulgaria as well (13).
This makes it difficult to provide accurate, reli-
able and comparable information for the sake of ac-
tivities valuation in hospital care. On the other hand, 
the price of some CPs does not include certain costs, 
for example costs for consumables, medicines, over-
heads, staff, food, etc.
Table 1 presents the data from the analyses of 
Ministry of Health and NCPHA, NHIF, Ministry of 
Finance regarding the average reimbursement pric-
es and the average cost per case for the period 2007 
– 2014.
When we summarize and compare the data in 
Table 1, we observe the great deviation in the average 
values for reimbursement prices of CPs for the peri-
od 2010-2012. According to the NHIF and the Minis-
try of Finance, the weighted average price of CPs was 
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BGN 716 in 2010, covering only the first four months 
of the respective year, while according to NCPHA 
the average price of the CPs was BGN 1152 for the 
entire 2010. Despite the inconsistency of the reported 
periods, there is significant variation in the values. A 
double difference in data for the average reimburse-
ment price for 2012 is notable. It is an interesting fact 
that the same lead authors of the studied problems 
indicate different average values of the CPs in their 
publications. This misleads the consumers of the in-
formation and raises doubts about the validity of the 
presented data.
Table 1 shows significant variations in the aver-
age cost per case for the different types of hospitals. 
The average costs in university hospitals exceed 1.60 
times the reimbursement levels for 2009 and 2010. 
Meanwhile, the average costs in the regional hospi-
tals are around 80% of the reimbursement cost while 
in municipal hospitals these costs reach 60-65% of 
the reimbursement price. Thorough analyses also 
suggest that part of the CPs are “undervalued” and 
another part “overvalued” as the value of CPs is not 
bound to the disease severity, accompanying diseas-
es, and the quality of treatment (8). Furthermore, the 
study shows that there is a lack of accessible informa-
tion regarding the costs of private hospitals in the pe-
riod 2007-2011.
The survey conducted by NCPHA with regard 
to assessing the efficiency of the CPs in the period 
2010-2012, used data from hospitals participating in 
the voluntary submission of information to the NC-
PHA through specialized software for hospitals (14). 
Based on the aggregated data from hospitals which 















2007 583 589 916 494 427 n/a n/a
2008 706 717 1117 589 465 n/a n/a





716 (NHIF, MF(9)) 
1152 (NCPHA (14))
759 1072 583 464 n/a n/a








1066 1146 652 487 897 1897
2013 656 890 1456 687 462 921 1032
2014 671 843 1249 698 510 860 1016
Source: For the period January, 2007- April, 2010, NHIF and Ministry of Finance (9) 
             For the entire 2010, NCPHA (14)
             For 2011, NCPHA and Ministry of Health (18)
             For the period 2012-2014, NCPHA and Ministry of Health (12,14)
*Others, including: former dispensaries, state-owned hospitals, specialized rehabilitation hospitals, diagnostic-consultative centres and 
medical centres performing hospital services.
Table 1. Average reimbursement prices of the clinical pathways and the average cost per case for the period January, 
2007 – December, 2014.
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for hospitals, the average prices of CPs have been cal-
culated and they were BGN 1152 in 2010, BGN 1163 
in 2011, and BGN 1295 for the first nine months of 
2012, respectively. Hence, this trend shows an in-
crease in the average cost of CPs. In the period 2010-
2011, the number of paths with low hospitalization 
(less than 20 patients a year) was 16 and 17, respec-
tively. There were also two of them where no patient 
was admitted. For the first nine months of 2012, 23 
CPs were with patient admission below the number 
of 20 and 4 of them have zero admissions. Accord-
ing to experts of NCPHA, the low utilization of these 
pathways means that the same have resource plan-
ning within the year, which is a hidden reserve for 
the reallocation in excess of other pathways (14).
Bulgarian researchers, again, analyzed the 
available data for costs distribution by hospital types 
and CPs for the period 2012 - 2014, based on data 
from specialized software for hospitals (12). They re-
ported a gradual decrease in the number of hospitals 
that submit data to NCPHA. Moreover, this study 
provides data for private hospitals. However, the rel-
ative share of cases with financial information de-
creases significantly, especially for these health care 
establishments. Table 2 presents the comparison be-
tween the average cost per case and the average cost 
of CP, as well as the relative share of the underfund-
ing of CPs at national level.
Overall, the data in Table 2 suggest that the av-
erage cost of CPs does not cover the costs generat-
ed by the patients. Moreover, the relative share of the 
underfinancing of CPs showed an almost twofold de-
crease between 2012 and 2014. The experts explain 
this phenomenon with the execution of the necessary 
activities concerning the clinical pathways only and 
an improvement of the management of patient care 
(12).
As of April 2014, a new methodology for valua-
tion of activities in hospital care is in force. Accord-
ing to it a new way for calculation of the uniform re-
imbursement prices of CPs is introduced through:
1. Summarizing the information from the in-pa-
tient health care establishments concerning 
the actual costs made by the different types of 
hospitals.
2. Calculation of the new uniform reimbursement 
prices by nonlinear transformation so that 
when relatively large overvaluation/undervalu-
ation of the CP is present, it approximates the 
new price to the actual cost.
3. Calculation of the necessary funds at national 
level based on the new uniform reimbursement 
prices and forecasts for the number of patients 
on CPs (15).
In 2015, the results of the analysis on CPs and 
health care establishments (in terms of the new 
methodology - the first 3 months, the first 6 months 
and 11 months) show that the inhomogeneity of CPs 
still persists. 155 CPs maintain the position overval-
ued/undervalued, and the number of those which 
change their position is 134, as 63 from the overval-
ued CPs pass into undervalued position. According 
to Salchev, cost structure by types of hospitals and 
CPs is different and these differences should be taken 
into account in the future (16). The conclusions and 
recommendations of the recent analysis of NCPHA 
regarding the hospitals funding are related to the de-
sign of a complex indicator that reflects not only the 
activity but also the movement of patients, the sever-
ity of the cases, etc.
Presented by us financial data are results, de-
rived from analyses and reports of the NHIF, the 
Ministry of Health, the NCPHA, and the Ministry of 
Finance which are the main institutions which dis-
Years Average cost per case 
Average reimbursement 
prices
Relative share of 
underfunding (%)
2012 1066.11 648.22** 39.20%
2013 890.24 656.03** 26.31%
2014 842.82 671.47** 20.33%
Source: NCPHA and Ministry of Health (12);  **Todorova R. Analysis of the stability of the health insurance model - the risks and 
challenges for the NHIF.
Table 2. Average cost per case, average reimbursement prices of the clinical pathways and the relative share of under-
funding of the clinical pathways at national level for the period 2012-2014.
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pense information from health care establishments 
in different sections. As mentioned above, currently, 
specialized software for hospitals is the only tool for 
analyzing the costs and their structure in the health 
care establishments. We have found that not all hos-
pitals submit information to the specialized software 
for hospitals. Overall, the number of health care es-
tablishments which submit financial and econom-
ic data diminishes, which is a precondition for dis-
tortion of information at a national level. This way, 
the average cost per patient will always be underval-
ued or overvalued compared to the average price of 
the CPs. As already mentioned, the prices of the CPs 
are determined according to methodologies adopt-
ed by a Government decree. A summary of the data 
from hospitals for actual costs incurred is necessary 
in order to calculate uniform reimbursement prices 
of the particular pathways. Davidov reasonably rais-
es the questions: which are the hospitals that the in-
formation on the “actual costs” is collected from and 
what is the applied methodology for the calculation 
of these costs? He presents other important issues as 
well. What is the underfinancing of the clinical path-
ways due to? Are these irrational costs made by the 
hospitals or problems with the development of their 
pricing by the NHIF? (17).
CONCLUSION
The accepted clinical pathways are not a suffi-
ciently effective mechanism for hospital funding in 
Bulgaria. When we observe only the data present-
ed in the tables, this conclusion is evident.  Behind 
the aggregate figures, however, lies a vast amount of 
data obtained by the various health care establish-
ments (costs by type, costs by supplementary activ-
ities, revenues, etc.). Unfortunately, most researches 
do not have access to this information. Therefore, in-
terpretation of the financial and economic data must 
be performed very carefully, pointing out the limita-
tions of the initial information and the applied sta-
tistical approaches and analyses. The lack of unified 
national information system covering all registered 
health care establishments means lack of accurate 
and comparable information that makes the analyses 
incomplete and vulnerable.
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